Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder

• Main Authors: Tsutomu Nagai (Author), Tatsuya Kurihara (Author), Hiroaki Koya (Author), Yukako Nakano (Author), Satoru Sugisawa (Author), Takehiko Sambe (Author), Keiko Kishimoto (Author), Mari Kogo (Author), Haruhisa Ota (Author), Akira Iwanami (Author), Naoki Uchida (Author)
• Format: Book
• Published: Wiley, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Aim Atomoxetine (ATX) is a non‐central stimulant and a standard treatment for adult attention‐deficit/hyperactivity disorder (ADHD). The long‐term efficacy of Atomoxetine is about 40% at 6 months. The variability in efficacy between individuals is thought to be related to patient‐specific f...